NYSE · Biotech stocks database

QGEN — Qiagen N.V. Common Shares

QGEN (Qiagen N.V. Common Shares) stock: $43.33, $8.93B market cap, $1.10B cash, $9.48B EV, $10.75B fully diluted market cap. Next expected readout: Oct-30. Data from Fully Diluted's biotech stocks database.

Share price

$43.33

Market cap

$8,929.2M

Cash

$1,098.9M

Enterprise value

$9,484.7M

Balance sheet

Cash	$1,098.9M
Debt	$1,654.4M
Net cash	-$555.5M
Enterprise value	$9,484.7M
Basic shares	206.1M shares
Fully diluted shares	248.0M shares
Fully diluted market cap	$10,746.8M
Cash per share	$5.33

Cash figures as of 2025-12-31. Database snapshot: 2026-09-21.

Price history

Loading QGEN daily closes…

Loading price history…

Upcoming catalysts

Expected	Drug	Phase	Indication	Mgmt guide
Jan 12 - Feb 23	NEU-411	Phase 2	Parkinson Disease; Parkinson; Idiopathic Parkinson Disease	—
Oct 27 - Dec 8	INCB161734	Phase 3	Solid Tumors	—

Estimated readout windows: registry primary-completion date + 6-12 weeks. Windows already open are shown from "Now". Drug names link to ClinicalTrials.gov.

Full readout calendar →

Active clinical trials

Trial	Phase	Status	Role	Sponsor	BP	Condition(s)	Mgmt guide
NCT06645236	Not disclosed	Recruiting	Sponsor	QGEN	—	Metastatic Colorectal Cancer (mCRC)	—
NCT06820060	Not disclosed	Active, not recruiting	Sponsor	QGEN	—	Meningitis; Encephalitis Infection	—
NCT06824129	Not disclosed	Active, not recruiting	Sponsor	QGEN	—	Complicated Urinary Tract Infection	—
NCT07522073	Phase 3	Recruiting	Collaborator	INCY	—	Solid Tumors	—
NCT06680830	Phase 2	Recruiting	Collaborator	Neuron23 Inc.	—	Parkinson Disease; Parkinson; Idiopathic Parkinson Disease	—

Sponsor-matched active trials from ClinicalTrials.gov (3 as sponsor, 2 as collaborator); "Sponsor" = company is the lead sponsor, "Collaborator" = company is a collaborator. The BP column flags big-pharma involvement as lead sponsor or collaborator (excluding the company itself). The Mgmt guide column shows what management guided for readout timing when a guided program matches the trial (hover for the quote, click for the source). Trial listings are not a company pipeline slide.

View all 5 active trials for QIAGEN Gaithersburg, Inc on ClinicalTrials.gov

Get the weekly biotech catalyst rundown.
Cash runways, financings, and trial readouts for all 714 stocks.

Subscribe to Compounding Ego